Navigation Links
Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
Date:10/28/2013

SUNNYVALE, Calif., Oct. 28, 2013 /PRNewswire/ -- Arrayit Corporation (OTCQB: ARYC), a leading life sciences and diagnostics company, announces today that the company has signed a seven-year commercial lease for its new corporate headquarters in Sunnyvale, California.

Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities. The new headquarters was leased from Dollinger, the prestigious Silicon Valley firm whose current tenants include Alcatel Lucent, Bed Bath & Beyond, Best Buy, Clear Channel, FedEx Corporation, Honeywell International, Kinko's, Samsung, Starbucks and Trader Joe's.

Arrayit is a microarray technology leader that sells its patented and proprietary discovery platform to researchers and clinical laboratories worldwide to empower exploration of the human genome, presymptomatic disease diagnostics and the development of safer and more effective pharmaceuticals.  The new Arrayit headquarters, located off East Argues Avenue near Apple and Pharmacyclics, will facilitate the company's ambitious expansion plans that include greater capitalization, expansion of the company's staff and board of directors, revenue and earnings growth, and appreciating shareholder value through a recent upward trend in ARYC stock price.

About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
- Powerful Science for Life™
- Visit www.arrayit.com for more information.

Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended June 30, 2013.


'/>"/>
SOURCE Arrayit Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
2. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
3. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
4. Genentech Purchases Arrayit Technology
5. Arrayit on Major Fundraising Drive
6. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
7. Psychemedics Corporation Announces Earnings Up 20% And Top Revenue Quarter
8. Comprehensive Care Corporation Announces Extension of $5 Million Credit Facility
9. Positron Announces Reverse Stock Split and Registration as a Delaware Corporation
10. Senior Executives of Cytyc Corporation, and Constitution Medical, Inc., Announce the Launch of ATON PARTNERS
11. OPTIMIZERx Corporation Announces the Resignation of the Companys Current CEO & Chairman Mr. Shadron L. Stastney
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017  Palladian Health, a leading provider ... launch of an opioid management program which assists ... and helps stem the growing tide of dependence ... treat chronic non-cancer pain (back pain, neck pain, ... lack of evidence regarding long-term effectiveness. ...
(Date:1/19/2017)... , Jan. 19, 2017 ... Summary GlobalData,s new report, "Germany Cataract Surgery Devices ... the Germany Cataract Surgery Devices market. The report provides ... and average prices (USD) within market segements - Phacoemulsification ... also provides company shares and distribution shares data for ...
(Date:1/19/2017)... Jan. 19, 2017 The U.S. Food and Drug ... Idiopathic Constipation (CIC) in adult patients. "No ... disorders," said Julie Beitz , M.D., director of the ... Drug Evaluation and Research. "With the availability of new therapies, ... for their condition." ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... ATP ... people’s everyday lives, recently attended the January ECRM Trade Show in Hilton Head, ... known for its large range of supplements that keep the body functioning at ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece of ... Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda Roberts, ... who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a story of ... Seymour, who lives in Lafayette, Indiana where she works in a daycare and looks ... writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is an adventure ...
(Date:1/19/2017)... ... , ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over ... (APMs) in 2017. Clinicians who participate in APMs are paid for the quality of ... Administration’s effort to build a system that delivers better care and one in which ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO ... the name of their drug rehab center in Delray Beach, Florida has been changed ... not only stars such as Philip Seymour Hoffman and Chris Farley are dying from ...
Breaking Medicine News(10 mins):